article thumbnail

US FDA approves Vertex’s Orkambi for cystic fibrosis in children

Pharmaceutical Technology

The treatment is indicated for CF patients who are homozygous for the F508del mutation (F/F genotype) in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. It enrolled 46 children aged one to under two years with the F/F genotype. According to the findings, Orkambi was found to be well tolerated.

article thumbnail

8 Frequently Asked Questions About Genetic Testing in Clinical Trials

Worldwide Clinical Trials

genotyping for known variants vs sequencing only vs sequencing and concurrent deletion/duplication analysis), and whether the interpretation of the genetic testing results may have changed over time. It is important to consider the type of testing performed (e.g., single gene testing vs comprehensive panel), the reportable range (e.g.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biorepositories as a Guiding Resource for Research & Drug Discovery

XTalks

Through these collaborations, cohort research dataset sharing programs allow for whole-genome sequence and genotype data to be made available for independent research. She says dynamics with respect to research goals, priorities and regulations have changed over the past decade. Genotype Data Curation and Return of Results.

article thumbnail

EMA reviewing Novartis’ Adakveo after phase 3 miss

pharmaphorum

The EU regulator’s Committee for Medicinal Products for Human Use (CHMP) said it will “assess the impact of these findings on the balance of benefits and risks of Adakveo” and the impact on its conditional approval, which was granted in 2020. That study showed that Adakveo lowered the median annual rate of VOCs to 1.63

article thumbnail

FDA Makes Low-Risk Determination for Marketing of Products from Genome-Edited Beef Cattle After Safety Review

The Pharma Data

The IGA results in the equivalent genotype (genetic make-up) and short-hair coat trait seen in some conventionally bred cattle, known as a “slick” coat. This is the FDA’s first low-risk determination for enforcement discretion for an IGA in an animal for food use. The low-risk determination was provided to Acceligen. Related Information.

Genome 52
article thumbnail

10 Key Learnings from Successful Cellular and Gene Therapy Trials for Rare Diseases

XTalks

These are, in my view, the most valid comparisons, particularly in inherited diseases where the genotype is obviously the same in each individual patient, and as a consequence, the difference in phenotype after gene therapy is a true difference,” he adds. As a result, there are several EU regulations and directives to follow.

article thumbnail

Top 30 New Medical Devices of 2024

XTalks

The tricuspid valve, one of the heart’s four valves, regulates blood flow from the right atrium to the right ventricle, preventing backflow between these chambers. The clip is designed with arms that can open and close, enabling it to securely attach to the hearts leaflets of the tricuspid valve.